Headquartered in Nashville, Tennessee with offices in Irvine, California and Shanghai, China Nashai Biotech, LLC is a product research, development and procurement company for dietary supplements, over-the-counter medications, and active pharmaceutical ingredients. In collaboration with Vanderbilt University Nashai Biotech was founded in 2001.
Nashai specializes in development of scientific data substantiated new ingredients for marketing through pharmaceutical and natural products companies with well-established marketing and distribution networks. Our products reflect a dedication to consumers and the medical community by offering quality, innovation and affordability. Through integration of academic collaborations, licensing agreements, and strategic business partnerships, Nashai is prepared to meet the health needs of consumers worldwide for both disease prevention and treatment.
The company is privately held, funded by angel investment, grants, and ongoing cash flow.
Nashai is the first company to identify the active ingredient (theaflavin) in tea that is linked to lowering cholesterol. Over the past few years, Nashai has perfected a process for extracting high concentration of theaflavins from tea leaves resulting in a specially blended product, Choleve®. Choleve® is a registered trademarks for Nashai. Choelve has been proven through human clinical trial to reduce lipid levels in humans, as published in “Cholesterol Lowering Effect of a Theaflavin-Enriched Green Tea Extract”.
The Chinese Ministry of Health issued a health food license to Nashai Biotech in December 2002, representing the first license granted by the Chinese government in this category and the first license issued for theaflavins. This license authorizes Nashai Biotech to manufacture and market Choleve® in China, for the treatment of cardiovascular disease, especially cholesterol reduction.
Nashai also holds a number of trademarks, approved patents and pending patents for products and manufacturing processes to produce specially blended tea extracts.